Jynarque 90MG/30MG
Ended Awarded
- Contract number
- 36C24523N0632
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,196
Award facts
- Contract value 100% obligated
- $12,195.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
On June 8, 2023, the Department of Veterans Affairs, specifically Veterans Integrated Service Network 5, awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 90mg/30mg tablets with a ceiling value of $12,195.72. This contract is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and utilizes an underlying Blanket Purchase Agreement valued at $83.3 million that enables VA facilities across multiple Integrated Service Networks to procure this specialty pharmaceutical. The award is structured as a firm fixed price delivery order with no set-aside designation, reflecting the established vendor relationship and streamlined procurement process for this critical medication.
Jynarque (tolvaptan) is a specialized pharmaceutical treatment for autosomal dominant polycystic kidney disease and hyponatremia, conditions requiring targeted therapeutic intervention for veteran populations. Otsuka America Pharmaceutical Inc., a Maryland-headquartered pharmaceutical manufacturer, has demonstrated consistent capability in supplying this medication to the VA through multiple delivery orders across various Integrated Service Networks. The contract's completion date of June 9, 2023, represents a single delivery order fulfilling immediate pharmaceutical needs at the Pittsburgh, Pennsylvania facility, supporting the VA's mission to provide specialized healthcare treatments to veterans nationwide.
Quick answers
Who was awarded contract 36C24523N0632?
36C24523N0632 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on June 8, 2023.
How much is contract 36C24523N0632 worth?
The government has obligated $12,196 on 36C24523N0632.
Is contract 36C24523N0632 an order under another contract?
Yes. 36C24523N0632 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0632 competed?
The extent of competition for 36C24523N0632 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award